Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer

Åsa Ehlén, Donal J. Brennan, Björn Nodin, Darran P. O'Connor, Jakob Eberhard, Maria Alvarado-Kristensson, Ian B. Jeffrey, Jonas Manjer, Jenny Brändstedt, Mathias Uhlen, Fredrik Ponten, Karin Jirström

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology